
Granules India Limited has informed the Exchange regarding a press release dated May 19, 2023, titled "Granules India Limited Received ANDA Approval for Venlafaxine ER Capsules".
Filed with NSE ·

Granules India Limited has informed the Exchange regarding a press release dated May 19, 2023, titled "Granules India Limited Received ANDA Approval for Venlafaxine ER Capsules".
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India